###begin article-title 0
Developmental Regulation of Hepatitis B Virus Biosynthesis by Hepatocyte Nuclear Factor 4alpha
###end article-title 0
###begin p 1
Conceived and designed the experiments: AM. Performed the experiments: LL CEO BS AM. Analyzed the data: LL CEO BS AM. Contributed reagents/materials/analysis tools: FJG. Wrote the paper: SLU AM.
###end p 1
###begin p 2
###xml 67 74 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 125 142 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 144 147 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 160 165 <span type="species:ncbi:10090">mouse</span>
###xml 357 360 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The host cellular factors that promote persistent viral infections in vivo are, in general, poorly understood. Utilizing the hepatitis B virus (HBV) transgenic mouse model of chronic infection, we demonstrate that the nuclear receptor, hepatocyte nuclear factor 4alpha (HNF4alpha, NR2A1), is essential for viral biosynthesis in the liver. The dependency of HBV transcription on HNF4alpha links viral biosynthesis and persistence to a developmentally regulated transcription factor essential for host viability.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 337 340 337 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Geeraert1">[1]</xref>
###xml 341 344 341 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Gale1">[4]</xref>
###xml 508 511 508 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Lok1">[5]</xref>
###xml 513 516 513 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Lavanchy1">[6]</xref>
###xml 641 644 641 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Lavanchy1">[6]</xref>
###xml 174 202 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
###xml 333 336 <span type="species:ncbi:9606">man</span>
###xml 346 349 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 396 402 <span type="species:ncbi:9606">people</span>
###xml 523 526 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 742 745 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 816 819 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
Persistent viral infections require the coexistence of pathogen and host for extended periods of time without the host resolving the infection or the virus killing the host. Human immunodeficiency virus, herpes simplex viruses, papillomaviruses and hepatitis B and C virus have evolved a variety of strategies to persistently infect man [1]-[4]. HBV chronically infects approximately 400 million people worldwide resulting in about a million deaths per year from liver cirrhosis and hepatocellular carcinoma [5], [6]. Most HBV infections worldwide occur in neonates at or around the time of birth and usually result in persistent infections [6]. Although the immunological immaturity of the neonate is presumed to contribute to these chronic HBV infections, a precise understanding of the molecular events governing HBV persistence during development is lacking.
###end p 4
###begin p 5
###xml 198 201 198 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Will1">[7]</xref>
###xml 296 299 296 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Tang1">[8]</xref>
###xml 709 712 685 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Tang2">[9]</xref>
###xml 0 3 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 675 678 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
HBV replicates its genomic DNA by reverse transcription of a pregenomic 3.5kb RNA which is transcribed from covalently closed circular 3.2kb viral genomic DNA in the nucleus of infected hepatocytes [7]. Thus transcriptional regulation plays a central role in controlling viral replication levels [8] and represents a potential antiviral target which has not, to date, been exploited clinically. In cell culture, the binding of hepatocyte nuclear factor 4alpha (HNF4alpha) or retinoid X receptor alpha (RXRalpha) plus peroxisome proliferator-activated receptor alpha (PPARalpha) to the nucleocapsid promoter regulatory elements governs the level of synthesis of this critical HBV pregenomic 3.5kb RNA template [9].
###end p 5
###begin p 6
###xml 429 436 421 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 721 725 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Hayhurst1">[10]</xref>
###xml 726 730 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Chen1">[12]</xref>
###xml 48 51 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 184 187 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 199 204 <span type="species:ncbi:10090">mouse</span>
###xml 222 225 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 312 315 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
In this study, we demonstrate that the level of HBV transcription and replication throughout early postnatal development correlates with the level of liver HNF4alpha expression in the HBV transgenic mouse model of chronic HBV infection. The conditional depletion of HNF4alpha in the liver results in the loss of HBV transcription and replication indicating that this nuclear receptor is a major determinant of viral biosynthesis in vivo. These observations indicate that viral transcription, biosynthesis and antigen expression will increase progressively after infection at birth, possibly contributing to persistent infection. Additionally, the essential nature of the HNF4alpha transcription factor for host viability [10]-[12] may limit the hosts' ability to resolve infection and increase the probability of viral persistence.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 71 74 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
Characterization of the conditional liver-specific HNF4alpha deficient HBV transgenic mouse during early postnatal development
###end title 8
###begin p 9
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Guidotti1">[13]</xref>
###xml 309 313 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Guidotti2">[14]</xref>
###xml 463 472 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4&#945;</italic>
###xml 472 477 456 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 486 490 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Hayhurst1">[10]</xref>
###xml 593 597 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Postic1">[15]</xref>
###xml 628 633 608 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 704 709 680 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 784 793 760 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4&#945;</italic>
###xml 799 803 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Hayhurst1">[10]</xref>
###xml 10 13 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 378 381 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 404 407 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 408 423 <span type="species:ncbi:10090">transgenic mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 634 649 <span type="species:ncbi:10090">transgenic mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
Using the HBV transgenic mouse (lineage 1.3.32) model of chronic infection [13], we previously demonstrated that PPARalpha did not affect the level of viral biosynthesis under normal physiological conditions but did mediate enhanced viral transcription and replication in response to peroxisome proliferators [14]. To determine the role of the transcription factor HNF4alpha in HBV biosynthesis, we bred HBV transgenic mice with mice carrying a floxed HNF4alpha (HNF4alphafl/fl) allele [10] and albumin Cre recombinase (lineage B6.Cg-Tg(Alb-cre)21Mgn/J, Jackson Laboratory) transgene (AlbCre) [15] to generate HBVAlbCreHNF4alphafl/fl transgenic mice. The presence of the AlbCre transgene in the HNF4alphafl/fl mice results in the postnatal liver-specific loss of exons 4 and 5 of the HNF4alpha gene [10].
###end p 9
###begin p 10
###xml 54 59 50 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 171 186 167 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g001">Figure 1A and B</xref>
###xml 290 299 286 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g001">Figure 1B</xref>
###xml 597 602 589 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 650 659 642 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g001">Figure 1B</xref>
###xml 1562 1566 1538 1542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Hayhurst1">[10]</xref>
###xml 1648 1652 1624 1628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Fenech1">[16]</xref>
###xml 1766 1775 1738 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g001">Figure 1C</xref>
###xml 1848 1852 1816 1820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Hayhurst1">[10]</xref>
###xml 1854 1858 1822 1826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Rhee1">[17]</xref>
###xml 60 75 <span type="species:ncbi:10090">transgenic mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 603 618 <span type="species:ncbi:10090">transgenic mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
###xml 1080 1084 <span type="species:ncbi:10090">mice</span>
###xml 1188 1192 <span type="species:ncbi:10090">mice</span>
###xml 1253 1257 <span type="species:ncbi:10090">mice</span>
###xml 1449 1453 <span type="species:ncbi:10090">mice</span>
###xml 1671 1675 <span type="species:ncbi:10090">mice</span>
From the initial crosses generating HBVAlbCreHNF4alphafl/fl transgenic mice, it was apparent that some of the pups were not growing at the same rate as their littermates (Figure 1A and B). Indeed, these pups were approximately 50% the weight of their littermates between age 1 and 2 weeks (Figure 1B) and failed to survive past 16 days. Genotyping of these mice demonstrated that all the pups with reduced growth were Cre positive (sCre(+); small, Cre positive). However, many of the Cre positive mice (Cre(+)) within the same litter displayed growth rates closer to normal mice (Cre(-); HNF4alphafl/fl transgenic mice lacking the AlbCre transgene) (Figure 1B). While the liver to body weight ratio was similar (3.5+/-0.6%) for the different groups of mice throughout the first two weeks of postnatal development, the sCre(+) mice displayed additional features not observed in the other two groups. sCre(+) mice sera displayed a light yellow-green coloration that became more apparent with age. Additionally, the livers of approximately two thirds of the 1- to 2-week-old sCre(+) mice displayed an olive-yellow coloration rather than the dark red-brown color typically observed in normal mice. Both of these observations are consistent with the sCre(+) mice having an altered phenotype due to loss of HNF4alpha in the liver. The observed changes in color of the sera and livers may be due to modest increases in circulating bile acids seen in these mice (Cre(-), Cre(+) and sCre(+) were 17+/-9 micromol/l, 21+/-6 micromol/l and 54+/-15 micromol/l, respectively) [10] or an accumulation of the green pigment, biliverdin, a breakdown product of heme [16]. Similar to adult mice lacking HNF4alpha in their livers, the sCre(+) pups also had reduced circulating glucose (Figure 1C) consistent with lower HNF4alpha regulated gluconeogenesis in the liver [10], [17].
###end p 10
###begin title 11
Effects of liver-specific conditional deletion of HNF4alpha on postnatal growth, serum glucose and HNF4alpha transcript levels.
###end title 11
###begin p 12
###xml 25 30 21 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 105 110 97 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 434 439 418 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 475 480 455 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 556 561 532 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
(A) HBVAlbCre(+)HNF4alphafl/fl pup with the small phenotype, sCre(+), and a control HBVAlbCre(-)HNF4alphafl/fl littermate, Cre(-), at 5.5 days of age. (B) Effect of postnatal age on body weight. (C) Effect of postnatal age on serum glucose levels. (D) Effect of postnatal age on wild-type HNF4alpha RNA levels in the liver measured by reverse transcription-quantitative polymerase chain reaction. Cre(-), control HBVAlbCre(-)HNF4alphafl/fl mice; Cre(+), HBVAlbCre(+)HNF4alphafl/fl mice with approximately wild-type phenotype; sCre(+), HBVAlbCre(+)HNF4alphafl/fl mice with the small phenotype.
###end p 12
###begin p 13
###xml 179 188 171 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g001">Figure 1D</xref>
###xml 190 194 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Hayhurst1">[10]</xref>
###xml 297 306 285 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g001">Figure 1D</xref>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
Wild-type HNF4alpha transcript levels were measured in the liver using reverse transcription-quantitative polymerase chain reaction analysis specific for HNF4alpha exons 4 and 5 (Figure 1D) [10]. This analysis demonstrated that while HNF4alpha levels increased during early postnatal development (Figure 1D), the sCre(+) pups had considerably lower levels of functional HNF4alpha transcripts compared to the Cre(+) or Cre(-) mice throughout this time period, consistent with their observed phenotype. Additionally, sCre(+) mice with altered sera and liver coloration were never observed after 16 days, suggesting that these pups either died due to the lack of HNF4alpha in their hepatocytes or partially recovered as synthesis of HNF4alpha returned to an adequate level during liver development presumably due to the outgrowth of hepatocytes where the HNF4alpha gene was not efficiently deleted by the Cre recombinase.
###end p 13
###begin title 14
###xml 94 97 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
Characterization of viral transcription in the conditional liver-specific HNF4alpha deficient HBV transgenic mouse during early postnatal development
###end title 14
###begin p 15
###xml 278 287 270 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g002">Figures 2</xref>
###xml 292 293 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g003">3</xref>
###xml 420 428 412 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g002">Figure 2</xref>
###xml 512 521 500 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g001">Figure 1D</xref>
###xml 647 655 631 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g002">Figure 2</xref>
###xml 828 836 808 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g002">Figure 2</xref>
###xml 932 939 912 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 25 28 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 29 44 <span type="species:ncbi:10090">transgenic mice</span>
###xml 306 309 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 310 325 <span type="species:ncbi:10090">transgenic mice</span>
###xml 374 377 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 675 679 <span type="species:ncbi:10090">mice</span>
###xml 809 812 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 916 919 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
These distinct groups of HBV transgenic mice (Cre(-), Cre(+) and sCre(+)) exhibiting different levels of functional HNF4alpha expression throughout early postnatal development permitted the role of HNF4alpha in viral transcription and replication in the liver to be determined (Figures 2 and 3). Wild-type HBV transgenic mice (Cre(-)) displayed about a ten-fold increase in HBV 3.5kb RNA from birth to two weeks of age (Figure 2). During the same time period, HNF4alpha levels increased approximately five-fold (Figure 1D). The Cre(+) mice which display slightly reduced levels of HNF4alpha in their liver also showed reduced viral transcription (Figure 2) while the sCre(+) mice, exhibiting a major reduction in HNF4alpha levels throughout this period of development, displayed drastically reduced levels of HBV transcription (Figure 2). Together these data demonstrate a clear correlation between the abundance of HBV transcripts in vivo and the level of HNF4alpha during development indicating that HNF4alpha is essential for viral RNA synthesis.
###end p 15
###begin title 16
###xml 0 3 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 37 40 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 41 56 <span type="species:ncbi:10090">transgenic mice</span>
HBV RNA transcripts in the livers of HBV transgenic mice throughout early postnatal development.
###end title 16
###begin p 17
###xml 319 322 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ayw</italic>
###xml 350 354 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Anderson1">[26]</xref>
###xml 393 398 389 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 434 439 426 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 515 520 503 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 627 632 611 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 79 82 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 271 274 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
###xml 585 588 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 633 648 <span type="species:ncbi:10090">transgenic mice</span>
(A) RNA (Northern) filter hybridization analysis of representative examples of HBV transcripts at various stages of postnatal liver development. The glyceraldehyde 3-phosphate dehydrogenase (GAPDH) transcript was used as an internal control for the quantification of the HBV 3.5 and 2.1kb RNAs. The probes used were HBVayw genomic DNA plus GAPDH cDNA[26]. Cre(-), control HBVAlbCre(-)HNF4alphafl/fl mice; Cre(+), HBVAlbCre(+)HNF4alphafl/fl mice with approximately wild-type phenotype; sCre(+), HBVAlbCre(+)HNF4alphafl/fl mice with the small phenotype. (B) Quantitative analysis of the HBV 3.5kb transcript in HBVAlbCreHNF4alphafl/fl transgenic mice. Trend lines were calculated using linear regression analysis.
###end p 17
###begin title 18
###xml 0 3 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 51 54 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 55 70 <span type="species:ncbi:10090">transgenic mice</span>
HBV DNA replication intermediates in the livers of HBV transgenic mice throughout early postnatal development.
###end title 18
###begin p 19
###xml 302 305 302 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ayw</italic>
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Anderson1">[26]</xref>
###xml 360 365 356 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 401 406 393 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 482 487 470 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 726 731 710 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 79 82 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 168 171 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 249 252 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 524 527 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 543 546 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 595 598 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 675 678 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 732 747 <span type="species:ncbi:10090">transgenic mice</span>
(A) DNA (Southern) filter hybridization analysis of representative examples of HBV replication intermediates (RI) at various stages of postnatal liver development. The HBV transgene (Tg) was used as an internal control for the quantification of the HBV replication intermediates. The probe used was HBVayw genomic DNA[26]. Cre(-), control HBVAlbCre(-)HNF4alphafl/fl mice; Cre(+), HBVAlbCre(+)HNF4alphafl/fl mice with approximately wild-type phenotype; sCre(+), HBVAlbCre(+)HNF4alphafl/fl mice with the small phenotype; Tg , HBV transgene; RC, HBV relaxed circular replication intermediates; SS, HBV single stranded replication intermediates. (B) Quantitative analysis of the HBV replication intermediates in HBVAlbCreHNF4alphafl/fl transgenic mice. Trend lines were calculated using linear regression analysis.
###end p 19
###begin title 20
###xml 92 95 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
Characterization of viral replication in the conditional liver-specific HNF4alpha deficient HBV transgenic mouse during early postnatal development
###end title 20
###begin p 21
###xml 154 162 150 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g003">Figure 3</xref>
###xml 220 229 212 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g001">Figure 1D</xref>
###xml 465 473 457 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g003">Figure 3</xref>
###xml 613 622 605 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g002">Figures 2</xref>
###xml 627 628 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g003">3</xref>
###xml 685 694 673 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g001">Figure 1D</xref>
###xml 901 908 885 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 137 140 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 596 599 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 850 853 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The lower levels of viral 3.5kb pregenomic RNA associated with diminished HNF4alpha abundance in the liver resulted in similarly reduced HBV replication (Figure 3). In agreement with the observed reduction of HNF4alpha (Figure 1D), the Cre(+) mice displayed reduced levels of viral DNA synthesis throughout the first two weeks of postnatal development and the appearance of viral replication intermediates was delayed by at least a day compared to the Cre(-) mice (Figure 3). Likewise, the sCre(+) mice displayed a drastic reduction in viral replication consistent with their much lower level of HBV transcripts (Figures 2 and 3) and considerably lower levels of HNF4alpha expression (Figure 1D). Therefore it appears that under normal physiological conditions a single transcription factor, HNF4alpha, controls the early developmental expression of HBV transcripts and consequently viral replication in vivo.
###end p 21
###begin title 22
Discussion
###end title 22
###begin p 23
###xml 154 157 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Tang2">[9]</xref>
###xml 377 384 369 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1370 1373 1338 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Tang2">[9]</xref>
###xml 1521 1528 1485 1492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 113 116 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 185 188 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 271 274 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 275 290 <span type="species:ncbi:10090">transgenic mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 535 538 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 724 728 <span type="species:ncbi:10090">Mice</span>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
###xml 907 910 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 954 958 <span type="species:ncbi:10090">Mice</span>
###xml 1223 1226 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1352 1355 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1647 1650 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
HNF4alpha binds the proximal regulatory element of the nucleocapsid promoter and activates the expression of the HBV 3.5kb pregenomic RNA in cell culture [9]. Likewise, the analysis of HBV transcription and replication throughout early postnatal development in wild-type HBV transgenic mice and mice conditionally deleted for HNF4alpha suggest that it serves the same function in vivo. HNF4alpha levels increase in the liver throughout the first two weeks of postnatal development and is associated with a concomitant increase in both HBV RNA transcripts and DNA replication intermediates. The liver-specific conditional disruption of HNF4alpha during this period of development was associated with two distinct phenotypes. Mice with a severe HNF4alpha deficiency in the liver displayed reduced growth, altered glucose homeostasis and a postnatal lethal phenotype. These mice synthesized limited amounts of HBV transcripts and replication intermediates. Mice that were close to displaying a normal phenotype with respect to growth and glucose homeostasis exhibited a modest decrease in liver HNF4alpha levels that was associated with a similar decrease in both viral RNA and DNA synthesis. These observations indicate that HBV transcription and hence viral replication is dependent on HNF4alpha. Although it is likely that HNF4alpha directly activates HBV transcription [9], it is also possible that HNF4alpha might control the expression of additional factors necessary for efficient viral transcription and replication in vivo. Additionally, the hepatotoxicity resulting from extensive HNF4alpha loss may contribute to the observed reduction in HBV transcription and replication by unknown mechanisms.
###end p 23
###begin p 24
###xml 144 151 140 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 361 365 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Hayhurst1">[10]</xref>
###xml 366 370 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Chen1">[12]</xref>
###xml 482 486 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Yamagata1">[18]</xref>
###xml 488 492 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Shih1">[19]</xref>
###xml 60 63 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 255 258 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 355 360 <span type="species:ncbi:10090">mouse</span>
###xml 407 410 <span type="species:ncbi:9606">man</span>
###xml 494 500 <span type="species:ncbi:9606">Humans</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 660 663 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 833 836 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
These studies highlight an interesting relationship between HBV biosynthesis and liver-specific gene expression. We show HNF4alpha is essential in vivo to sustain active viral transcription and subsequent replication. Similarly, HNF4alpha is required for HBV host viability. The absence of HNF4alpha or its conditional loss from the liver is fatal in the mouse [10]-[12]. Haploinsufficiency of HNF4alpha in man is responsible for maturity onset diabetes of the young type 1 (MODY1) [18], [19]. Humans with a complete loss of HNF4alpha have not been reported presumably because, as in mice, it results in early embryonic lethality. Curiously, the adaptation of HBV to utilize HNF4alpha, an essential host gene product, guarantees constitutive replication of its genome as long as the host is viable. This adaptation may contribute to HBV persistence and offer the virus a significant selective advantage over other pathogens that utilize cellular components that are less important to host survival.
###end p 24
###begin p 25
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Dienstag1">[20]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-DelCanho1">[21]</xref>
###xml 627 631 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Dienstag1">[20]</xref>
###xml 633 637 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Milich1">[22]</xref>
###xml 801 805 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Guidotti2">[14]</xref>
###xml 21 24 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 136 139 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 344 347 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 441 444 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The vast majority of HBV infections acquired in adolescence and early adulthood are successfully cleared by the host. In contrast, most HBV infections that occur at birth result in chronic infection [20] despite the ability of neonates to mount an antiviral immune response if vaccinated [21]. The parallel increase in HNF4alpha expression and HBV biosynthesis levels observed during postnatal development in our study suggest that neonatal HBV infection is associated with a slow developmentally regulated increase in viral transcription, replication and antigen expression which may contribute to life long chronic infection [20], [22]. Therapeutic interventions that alter the expression levels of viral gene products at this stage of development, such as the fibrate class of hyperlipidemic drugs [14], might modulate the immune response of the host to viral antigens and help immunological resolution of these neonatal infections.
###end p 25
###begin p 26
###xml 475 483 467 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005489-g001">Figure 1</xref>
###xml 858 862 842 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Dienstag1">[20]</xref>
###xml 1166 1170 1138 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Shaw1">[23]</xref>
###xml 1172 1176 1144 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Shlomai1">[24]</xref>
###xml 21 24 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 385 388 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 577 580 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 661 664 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 832 835 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 1132 1135 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
The observation that HBV is critically dependent on at least one cellular factor offers a unique target for antiviral therapy. However this opportunity comes with the difficult challenge of inhibiting HNF4alpha without completely eliminating its essential cellular functions. Nevertheless, mice exhibiting only a modest decrease in HNF4alpha levels displayed a detectable reduction in HBV RNA and DNA levels while maintaining virtually normal growth and glucose homeostasis (Figure 1). Furthermore, newborn pups express enough HNF4alpha for viability but not enough to support HBV replication. If HNF4alpha activity levels can be attenuated clinically to limit HBV biosynthesis while minimally affecting liver physiology, this might offer a novel therapeutic strategy to complement currently available antiviral drugs targeting the HBV reverse transcriptase [20]. Metformin, a drug widely used to treat type 2 diabetes, reduces peroxisome proliferator-activated receptor gamma coactivator 1alpha expression and gluconeogenesis in the liver suggesting pharmacological intervention may be successful in decreasing HNF4alpha-dependent HBV transcription and replication [23], [24].
###end p 26
###begin title 27
Materials and Methods
###end title 27
###begin title 28
Ethics statement
###end title 28
###begin p 29
All animal experiments were performed according to institutional guidelines with Institutional Biosafety and Animal Care Committee approval.
###end p 29
###begin title 30
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice
###end title 30
###begin p 31
###xml 45 49 45 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Guidotti1">[13]</xref>
###xml 89 98 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4&#945;</italic>
###xml 98 103 90 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 112 116 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Hayhurst1">[10]</xref>
###xml 207 211 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Postic1">[15]</xref>
###xml 242 247 230 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 361 365 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Lee1">[25]</xref>
###xml 408 413 392 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 582 586 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Anderson1">[26]</xref>
###xml 665 701 645 681 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCGATACCTGAACCTTTACCCCGTTGCCCG-3&#8242;</named-content>
###xml 753 789 733 769 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCGAATTGCTGAGAGTCCAAGAGTCCTCTT-3&#8242;</named-content>
###xml 1021 1051 997 1027 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCAGCTAAACATGCTTCATCGTCG-3&#8242;</named-content>
###xml 1070 1100 1046 1076 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATTCTCCCACCGTCAGTACGTGAG-3&#8242;</named-content>
###xml 1322 1350 1290 1318 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGAATGACCCTGAAGCACCAGG-3&#8242;</named-content>
###xml 1376 1404 1344 1372 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCAGAGGTCTGTGAAACAAGG-3&#8242;</named-content>
###xml 1576 1580 1536 1540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Hayhurst1">[10]</xref>
###xml 8 11 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 12 27 <span type="species:ncbi:10090">transgenic mice</span>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 248 263 <span type="species:ncbi:10090">transgenic mice</span>
###xml 273 278 <span type="species:ncbi:10090">mouse</span>
###xml 414 429 <span type="species:ncbi:10090">transgenic mice</span>
###xml 431 435 <span type="species:ncbi:10090">Mice</span>
###xml 458 461 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 592 595 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 719 722 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 807 810 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 926 929 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
We bred HBV transgenic mice (lineage 1.3.32) [13] with mice carrying a floxed HNF4alpha (HNF4alphafl/fl) allele [10] and albumin Cre (lineage B6.Cg-Tg(Alb-cre)21Mgn/J, Jackson Laboratory) transgene (AlbCre) [15] to generate HBVAlbCreHNF4alphafl/fl transgenic mice. All the mouse strains had been crossed for twelve generations onto the SV129 genetic background [25] prior to generating the HBVAlbCreHNF4alphafl/fl transgenic mice. Mice were screened for the HBV transgene, the AlbCre transgene and the floxed HNF4alpha allele by polymerase chain reaction (PCR) analysis of tail DNA [26]. The HBV transgene was identified by PCR analysis using the oligonucleotides, 5'-TCGATACCTGAACCTTTACCCCGTTGCCCG-3' (oligo XpHNF4-1, HBV coordinates 1133 to 1159) and 5'-TCGAATTGCTGAGAGTCCAAGAGTCCTCTT-3' (oligo CpHNF4-2, HBV coordinates 1683 to 1658), and 1 microl of tail DNA. A PCR product of 551 base pairs indicated the presence of the HBV transgene. The AlbCre transgene was identified by PCR analysis using the oligonucleotides, 5'-CCAGCTAAACATGCTTCATCGTCG-3' (oligo CRE-1) and 5'-ATTCTCCCACCGTCAGTACGTGAG-3' (oligo CRE-2), and 1 microl of tail DNA. A PCR product of 300 base pairs indicated the presence of the Cre transgene. The HNF4alpha wild-type and floxed alleles were identified by PCR analysis using the oligonucleotides, 5'-AGAATGACCCTGAAGCACCAGG-3' (oligo prH4GTLP1-F1) and 5'-GCCAGAGGTCTGTGAAACAAGG-3' (oligo prH4GT-LP1-R1), and 1 microl of tail DNA. PCR products of 180 and 241 base pairs indicated the presence of the wild-type and floxed HNF4alpha alleles, respectively [10]. Serum glucose levels were measured using a SureStep blood glucose meter (Lifescan).
###end p 31
###begin title 32
###xml 0 3 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
HBV DNA and RNA analysis
###end title 32
###begin p 33
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Sambrook1">[27]</xref>
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Chomczynski1">[28]</xref>
###xml 170 173 166 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hin</italic>
###xml 191 195 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Sambrook1">[27]</xref>
###xml 222 224 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 237 240 233 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ayw</italic>
###xml 253 257 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Galibert1">[29]</xref>
###xml 394 398 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Sambrook1">[27]</xref>
###xml 425 427 417 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 440 443 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ayw</italic>
###xml 603 607 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005489-Sabath1">[30]</xref>
###xml 46 49 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 50 65 <span type="species:ncbi:10090">transgenic mice</span>
###xml 268 271 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 466 469 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 484 489 <span type="species:ncbi:10090">mouse</span>
Total DNA and RNA were isolated from liver of HBV transgenic mice as described [27], [28]. DNA (Southern) filter hybridization analyses were performed using 20 microg of HindIII digested DNA [27]. Filters were probed with 32P-labeled HBVayw genomic DNA [29] to detect HBV sequences. RNA (Northern) filter hybridization analyses were performed using 10 microg of total cellular RNA as described [27]. Filters were probed with 32P-labeled HBVayw genomic DNA to detect HBV sequences and mouse glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA to detect the GAPDH transcript used as an internal control [30]. Filter hybridization analyses were quantitated by phosphorimaging using a Packard Cyclone Storage Phosphor System.
###end p 33
###begin p 34
###xml 772 793 734 755 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCAACGCGCTCCTGC-3&#8242;</named-content>
###xml 827 853 785 811 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AATCTTCTTTGCCCGAATGT-3&#8242;</named-content>
###xml 891 916 845 870 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCTGGAAAGCTGTGGCGTG-3&#8242;</named-content>
###xml 948 974 902 928 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCAGTGAGCTTCCCGTTCAG-3&#8242;</named-content>
###xml 119 124 <span type="species:ncbi:10090">mouse</span>
###xml 729 734 <span type="species:ncbi:10090">mouse</span>
###xml 918 923 <span type="species:ncbi:10090">mouse</span>
###xml 976 981 <span type="species:ncbi:10090">mouse</span>
Reverse transcription-quantitative polymerase chain reaction was used to measure the level of HNF4alpha transcripts in mouse liver RNA. After DNase I treatment, 1 microg of RNA was used for cDNA synthesis using the TaqMan reverse transcription reagents (Applied Biosystems, Foster City, CA), followed by real-time PCR quantification using SYBR Green and an Applied Biosystems 7300 real-time thermocycler (Applied Biosystems). Thermal cycling consisted of an initial denaturation step for 10 min at 95degreesC followed by 40 cycles of denaturation (15 sec at 95degreesC) and annealing/extension (1 min at 60degreesC). The relative HNF4alpha RNA expression levels were estimated using the DeltaDeltaCt method with normalization to mouse GAPDH RNA. The PCR primers used were 5'-TCAACGCGCTCCTGC-3' (HNF4alpha exon 4 sense primer), 5'-AATCTTCTTTGCCCGAATGT-3' (HNF4alpha exon 5 antisense primer), 5'-TCTGGAAAGCTGTGGCGTG-3' (mouse GAPDH sense primer) and 5'-CCAGTGAGCTTCCCGTTCAG-3' (mouse GAPDH antisense primer).
###end p 34
###begin p 35
###xml 114 117 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 118 133 <span type="species:ncbi:10090">transgenic mice</span>
###xml 346 349 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 350 365 <span type="species:ncbi:10090">transgenic mice</span>
We thank Luca G. Guidotti and Francis V. Chisari (The Scripps Research Institute, La Jolla, CA) for providing the HBV transgenic mice. We thank Linda Kenney, Bellur Prabhakar, David Ucker and William Walden for many helpful discussions and critical reading of the manuscript. We are grateful to Iain McLachlan for the photographic imaging of the HBV transgenic mice.
###end p 35
###begin title 36
References
###end title 36
###begin article-title 37
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Hide-and-seek: the challenge of viral persistence in HIV-1 Infection.
###end article-title 37
###begin article-title 38
Chromatin control of herpes simplex virus lytic and latent infection.
###end article-title 38
###begin article-title 39
Immunobiology of HPV and HPV vaccines.
###end article-title 39
###begin article-title 40
###xml 41 58 <span type="species:ncbi:11103">hepatitis C virus</span>
Evasion of intracellular host defence by hepatitis C virus.
###end article-title 40
###begin article-title 41
Management of hepatitis B: 2000 - Summary of a workshop.
###end article-title 41
###begin article-title 42
###xml 0 17 <span type="species:ncbi:10407">Hepatitis B virus</span>
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.
###end article-title 42
###begin article-title 43
###xml 24 47 <span type="species:ncbi:10407">human hepatitis B virus</span>
Replication strategy of human hepatitis B virus.
###end article-title 43
###begin article-title 44
###xml 0 17 <span type="species:ncbi:10407">Hepatitis B virus</span>
Hepatitis B virus transcription and replication.
###end article-title 44
###begin article-title 45
###xml 30 47 <span type="species:ncbi:10407">hepatitis B virus</span>
Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism.
###end article-title 45
###begin article-title 46
Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.
###end article-title 46
###begin article-title 47
Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis.
###end article-title 47
###begin article-title 48
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos.
###end article-title 48
###begin article-title 49
###xml 11 28 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 44 59 <span type="species:ncbi:10090">transgenic mice</span>
High-level hepatitis B virus replication in transgenic mice.
###end article-title 49
###begin article-title 50
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 22 39 <span type="species:ncbi:10407">hepatitis B virus</span>
In vivo regulation of hepatitis B virus replication by peroxisome proliferators.
###end article-title 50
###begin article-title 51
Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.
###end article-title 51
###begin article-title 52
Hepatitis with biliverdinaemia in association with indomethacin therapy.
###end article-title 52
###begin article-title 53
Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): Requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.
###end article-title 53
###begin article-title 54
Mutations in the hepatocyte nuclear factor-4alpha gene in maturity- onset diabetes of the young (MODY1).
###end article-title 54
###begin article-title 55
Genotype/phenotype relationships in HNF-4alpha/MODY1 - Haploinsufficiency is associated with reduced apolipoprotein(AII), apolipoprotein(CIII), lipoprotein(a), and triglyceride levels.
###end article-title 55
###begin article-title 56
###xml 0 17 <span type="species:ncbi:10407">Hepatitis B virus</span>
Hepatitis B virus infection.
###end article-title 56
###begin article-title 57
Immunogenicity of two different dosages (10 and 5 microg) of recombinant DNA hepatitis B vaccine in healthy neonates.
###end article-title 57
###begin article-title 58
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in utero</italic>
Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
###end article-title 58
###begin article-title 59
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
###end article-title 59
###begin article-title 60
###xml 20 37 <span type="species:ncbi:10407">hepatitis B virus</span>
PGC-1alpha controls hepatitis B virus through nutritional signals.
###end article-title 60
###begin article-title 61
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.
###end article-title 61
###begin article-title 62
###xml 154 171 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 173 176 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 239 242 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 243 258 <span type="species:ncbi:10090">transgenic mice</span>
Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgenic mice.
###end article-title 62
###begin article-title 63
Molecular cloning: a laboratory manual.
###end article-title 63
###begin article-title 64
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
###end article-title 64
###begin article-title 65
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 27 44 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 76 83 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.
###end article-title 65
###begin article-title 66
Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2- induced transcript in a cloned T-helper lymphocyte.
###end article-title 66
###begin p 67
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 67
###begin p 68
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by Public Health Service grants AI30070 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 68

